• Error loading component: com_content, 1
  • Error loading component: com_content, 1
  • Error loading component: com_content, 1

biib New York, April 4th ( - Shares of Biogen Idec Inc. (NASDAQ:BIIB) booked a new 52 week high today by trading above $128.87, traders are definitely monitoring Biogen's price action to see if this move attracts further buying into the stock.

Biogen Idec Inc. (NASDAQ:BIIB) develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The products from the biotechnology company addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis. The company was founded in 1985 and is based in

Biogen Idec is currently trading 0.36% versus its previous trading session close, and it has calculated support and resistance at $116.44 and $127.85 respectively. Clearly, with this action this range has been penetrated, and traders will be reviewing price action to establish a new tradable range.

The overall market index S&P 500 is trading lower by -1.18% from its previous trading close, which means that Biogen Idec stock is outperforming the overall market.

TradersHuddle Search

Stock Search:

Site Search:


Technical Scans

Recent Trading Ideas

Latest Partner Headlines

Stock Market

o Dow Jones 18,075.94 ▼87.05 (-0.48%)
o S&P 500 2,113.84 ▼9.64 (-0.45%)
o NASDAQ 5,087.56 ▼19.03 (-0.37%)

Dow Jones

Company ID [INDEXDJX:.DJI] Last trade:18,075.94 Trade time:12:01PM EDT Value change:▼87.05 (-0.48%)

S&P 500

Company ID [INDEXSP:.INX] Last trade:2,113.84 Trade time:12:01PM EDT Value change:▼9.64 (-0.45%)


Company ID [INDEXNASDAQ:.IXIC] Last trade:5,087.56 Trade time:12:01PM EDT Value change:▼19.03 (-0.37%)

In The Wires

Copyright © 2013 All Rights Reserved.